Is the 12-lead electrocardiogram of value in the prognostic assessment of patients with hypertrophic cardiomyopathy?

Is the 12-lead electrocardiogram of value in the prognostic assessment of patients with hypertrophic cardiomyopathy?

Bibliographic Details
Main Authors:	Udelson James E, Haas Tammy S, Lesser John R, Gibson C Michael R, Biller Leah, Buros Jacqueline L, Harrigan Caitlin, Appelbaum Evan, Rowin Ethan J, Manning Warren J, Maron Barry J, Maron Martin S
Format:	Article
Language:	English
Published:	BMC 2010-01-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance
by: Manning Warren J, et al.
Published: (2008-10-01)

2055 Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy
by: Manning Warren J, et al.
Published: (2008-10-01)

Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy
by: Udelson James, et al.
Published: (2010-01-01)

233 Evidence that post-contrast delayed enhancement identified by cardiovascular magnetic resonance is an arrhythmogenic substrate in hypertrophic cardiomyopathy
by: Udelson James E, et al.
Published: (2008-10-01)

Characterization of tissue heterogeneity by contrast-enhanced cardiovascular magnetic resonance imaging is a powerful predictor of ventricular tachyarrhythmias on ambulatory holter ECG in hypertrophic cardiomyopathy
by: Manning Warren J, et al.
Published: (2009-01-01)

The necessity for full ventricular coverage with noncontrast T1 mapping in hypertrophic cardiomyopathy
by: Rowin Ethan, et al.
Published: (2013-01-01)

Noncontrast T1 values do not correlate to clinically relevant variables in patients with hypertrophic cardiomyopathy
by: Rowin Ethan, et al.
Published: (2013-01-01)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
by: Ahmed S. Fahmy, et al.
Published: (2021-05-01)

2027 Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance thresholding techniques
by: Gibson C Michael, et al.
Published: (2008-10-01)

2049 Improved detection of myocardial fibrosis using high-resolution, late gadolinium-enhanced cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
by: Gibson C Michael, et al.
Published: (2008-10-01)

Characterization of patients with massive hypertrophic cardiomyopathy using contrast-enhanced magnetic resonance imaging: does contrast provide additional information?
by: Chan Raymond H, et al.
Published: (2012-02-01)

Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
by: Manning Warren J, et al.
Published: (2009-01-01)

Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
by: Maron Martin S
Published: (2012-02-01)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
by: Johnson Francis, et al.
Published: (2005-04-01)

HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY
by: N. T. Vatutin, et al.
Published: (2014-05-01)

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
by: Bradley A. Maron, et al.
Published: (2021-02-01)

Risk stratification in hypertrophic cardiomyopathy: Time to think about the electrocardiogram
by: Jonathan R. Skinner
Published: (2019-04-01)

2075 Papillary muscles and trabeculations significantly impact ventricular volume, ejection fraction, and regurgitation assessment by cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
by: Manning Warren J, et al.
Published: (2008-10-01)

Cardiac Sarcoidosis Mimicking Hypertrophic Cardiomyopathy
by: Daniel R. Feldman, MD, et al.
Published: (2020-11-01)

Effect of Left Ventricular Outflow Tract Obstruction on Left Atrial Mechanics in Hypertrophic Cardiomyopathy
by: Lynne K. Williams, et al.
Published: (2015-01-01)

Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation
by: Amy Larson, et al.
Published: (2021-03-01)

Response to Skinner: Risk stratification in hypertrophic cardiomyopathy: Time to think about the electrocardiogram
by: Juan Pablo Kaski
Published: (2019-04-01)

Comparison of right ventricular involvement in AL and transthyretin-type cardiac amyloidosis by cardiovascular magnetic resonance
by: Tripp Kenneth, et al.
Published: (2009-01-01)

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
by: A. G. Osiev, et al.
Published: (2016-02-01)

Hypertrophic cardiomyopathy
by: Murillo de Oliveira Antunes, et al.
Published: (2020-04-01)

Hypertrophic Cardiomyopathy
by: Polakit Teekakirikul, MD, et al.
Published: (2021-09-01)

Hypertrophic obstructive cardiomyopathy (HOCM)
by: B. Pojskić, et al.
Published: (2006-02-01)

Continuous electrocardiogram changes preceding phenotypic expression for 8 years in an athlete with hypertrophic cardiomyopathy: a case report
by: Dan Han, et al.
Published: (2019-03-01)

Hypertrophic Cardiomyopathy: A Review
by: Brian A. Houston, et al.
Published: (2015-01-01)

Hypertrophic Cardiomyopathy: A Review
by: Brian A. Houston, et al.
Published: (2014-01-01)

Hypertrophic Cardiomyopathy with a Twist
by: W. Francis, et al.
Published: (2021-10-01)

Application of proteomics to human hypertrophic cardiomyopathy
by: Coats, C. J.
Published: (2016)

1003 TIMI myocardial perfusion grade predicts infarct size, perimeter and border zone following STEMI
by: Manning Warren J, et al.
Published: (2008-10-01)

ELECTROCARDIOGRAM ABNORMALITIES IN RELATION TO IDIOPATHIC CARDIOMYOPATHY IN DOGS
by: R. Vijayan, et al.
Published: (2003-01-01)

ELECTROCARDIOGRAM ABNORMALITIES IN RELATION TO IDIOPATHIC CARDIOMYOPATHY IN DOGS
by: R. Vijayan, et al.
Published: (2014-01-01)

Hypertrophic cardiomyopathy: an autopsy analysis of 14 cases.
by: Phadke R, et al.
Published: (2001-07-01)

HYPERTROPHIC CARDIOMYOPATHY IN MULTIMORBIDITY
by: A. I. Lakhonina, et al.
Published: (2016-06-01)

Management of Hypertrophic Cardiomyopathy
by: Alan D. Enriquez, et al.
Published: (2014-04-01)

Hypertrophic Cardiomyopathy in Adolescence
by: Paul F. Kantor, MBBCh, MSc, et al.
Published: (2021-01-01)

Mavacamten for hypertrophic cardiomyopathy: Effectiveness and value
by: Beinfeld, M., et al.
Published: (2022)